TherapeuticsMD reported $6.7M in Stock for its fiscal quarter ending in September of 2022.





Stock Change Date
AbbVie USD 5.31B 178M Sep/2026
Cipla INR 67.78B 1.82B Sep/2026
Clal Biotechnology ILS 4.44M 0 Mar/2021
CSL USD 6.47B 327M Jun/2025
Grifols EUR 3.56B 63.19M Dec/2024
Novo Nordisk DKK 51.35B 8.5B Mar/2026
Pfizer USD 10.02B 77M Sep/2026
TherapeuticsMD USD 6.7M 551K Sep/2022